Markets
Huntington Ingalls USS Gerald Ford
The USS Gerald R. Ford leaves Huntington Ingalls’ Newport News Shipbuilding for trials in 2017 (US Navy/Getty Images)

Huntington Ingalls board members who almost never buy company stock bought just before Trump’s speech sent it sky-high

An accounting professor who studies trading by corporate insiders described the transactions as “very unusual.”

Three directors of Huntington Ingalls Industries, one of America’s largest military shipbuilders, hadn’t bought a penny’s worth of company stock in years. But last month, just ahead of President Trump’s State of the Union address that included a surprise promise to “resurrect” the US shipbuilding industry, they decided to place buy orders.

Huntington Ingalls’ chairman, retired US Navy Admiral Kirkland H. Donald, and directors John K. Welch and Thomas C. Schievelbein bought stock on February 27, February 26, and February 13, respectively. Trump made his shipbuilding proclamation on the evening of March 4, catalyzing a 12.4% spike in Huntington Ingalls shares the next day. That was the single best day for the company’s stock since it went public in 2011. 

The nearly 3,700 shares the directors bought went up in value by more than $90,000 that day, and as of Friday's trading, they’ve gained in value by roughly another $10,000 since then. No SEC filings have indicated that the board members have sold shares since those purchases.

While all three men have relatively sizable holdings of the company’s shares, they’ve been largely awarded as part of their compensation packages for being board members. They rarely, if ever, buy shares on the open market. 

Prior to the February purchases, there are no records of Donald, a Huntington director since 2017, or Welch, a director since 2015, purchasing Huntington stock on the open market in recent history. The only somewhat recent record of purchases by Schievelbein, who’s been a director since 2011, occurred in March 2020 during the sharp sell-off in the market because of COVID-19. 

Daniel Taylor, professor of accounting at the University of Pennsylvania’s Wharton School, studies trading by corporate insiders. He reviewed SEC records related to the trades and described the transactions as “very unusual” in light of the fact that the men had done little, if any, active trading in the past. 

“The timing of these trades in a major shipbuilder, by members of the board of that shipbuilder, less than one week before the president announces a new shipbuilding initiative is highly suspicious,” Taylor said. 

In response to a series of questions related to the stock purchases, Danny Hernandez, director of public affairs at Huntington Ingalls, wrote in a statement: “We do not provide specifics relating to our directors. We maintain robust policies and procedures governing trading, and these are publicly available with the company’s public filings at SEC.gov. They were followed as expected with respect to the transactions at issue.”

The directors themselves also declined to comment, Hernandez said.

Trump’s announcement was a needed piece of good news for Huntington Ingalls, which was effectively Northrop Grumman’s shipbuilding division before it was spun off as an independent public company in 2011. 

For most of the last decade, the company had performed well, but since the stock hit a high last March, its share price had dropped roughly 40% as it struggled with labor and supply-chain issues that hampered production, as well as the slow pace of Navy contracting. But the stock is up about 14% since Trump’s State of the Union address, outpacing a nearly 3% drop in the S&P 500. 

“We used to make so many ships,” Trump told the joint session of Congress. “We don’t make them anymore very much, but we’re going to make them very fast, very soon.” He added that he hopes to offer special tax incentives for the industry. 

Subsequent reporting from Reuters, citing White House documents the news service reviewed, suggests the administration is preparing an executive order that would create a Maritime Security Trust Fund to disperse tax credits, grants, and loans to boost American shipbuilding. 

The trust fund would be paid for in part by levies charged on imports delivered to the US on Chinese-made ships. The Office of the US Trade Representative has recently taken initial bureaucratic steps toward implementing such fees

More Markets

See all Markets

Oil-sensitive travel stocks pop following Iran state media reporting on potential war resolution

Travel stocks are surging on Tuesday as oil prices fall following reports from Iranian state media that Iran's President Masoud Pezeshkian said the country has "the necessary will to end this war," but would only do so with guarantees that "prevent the recurrence of aggression."

The war has sent oil prices and refining margins surging this month, causing airlines and cruise lines to cut profit forecasts despite reported high demand.

Following Tuesday’s update, shares of the big four US airlines (Delta Air Lines, United Airlines, American Airlines, and Southwest Airlines) all climbed, along with smaller rivals including JetBlue. US airlines have stopped fuel hedging in recent years, increasing their exposure to upward swings in oil prices.

Cruise stocks also rallied, with Carnival and Norwegian up more than 6% and Royal Caribbean up about 5%.

markets

The FDA is expected to lift restrictions on certain peptides, the NYT reports

The Food and Drug Administration is expected to lift restrictions on certain peptides, allowing the experimental, often injectable substances to be sold by compounding pharmacies, The New York Times reported Tuesday.

The potential move was previously reported by The Wall Street Journal, and teased by Health Secretary Robert F. Kennedy Jr. on the “Joe Rogan Experience” podcast in late February.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

Peptides have boomed in popularity recently, with search interest for “peptides” surpassing “ozempic” this month. Many of them are currently understudied and not approved for human use, a rule consumers are able to bypass by purchasing them from suppliers that sell them for, ostensibly, research purposes only.

As reports of the FDA changing its stance of peptides mount, consumer health companies like Hims & Hers and Superpower have been getting ready to roll out their peptide offerings as soon as they get the FDA's blessing.

markets

Memory stocks bounce as Bernstein analyst calls TurboQuant fears “overdone”

Memory stocks rose Tuesday, after Bernstein analysts called the recent panic over Google’s TurboQuant AI algorithm “overdone.”

Bernstein analyst Mark Newman wrote:

“[Hard disk drive] and Memory stocks have sold off significantly due in part to fears from Google’s TurboQuant report. This however, should have zero impact on HDD demand and negligible impact on NAND demand. Given the stock sell-off we see this as an attractive entry point for Seagate Technology Holdings, Western Digital and Sandisk’s and upgrade WDC to Outperform.”

All three stocks were up early Tuesday, as was memory chip maker Micron.

Todays rally stands in stark contrast to the pummeling these shares have endured over the last week, after Google Research published a technical paper on March 24 detailing its TurboQuant AI algorithm, which compresses the amount of data associated with AI operations without affecting the accuracy of AI models.

That was seen as a threat to surging AI demand for memory storage, which has supercharged prices for memory chips and memory-related stocks over the last year.

markets

Constellation tumbles after posting underwhelming guidance, failing to announce new data center deals

AI power trade Constellation Energy tumbled early Tuesday after issuing an investor day update the market seemed to find unsatisfactory.

The company introduced full-year 2026 operating earnings guidance of between $11 and $12 a share, the midpoint of which is shy of consensus expectations for $11.73, according to FactSet.

Over at Barron’s, Avi Salzman suggested that the company’s failure to unveil any new data center deals as part of the festivities is also adding the the sell-off. He wrote:

“Constellation CEO Joe Dominguez said at the event that he anticipates signing major new deals to provide power to tech companies, but doesn’t want to announce anything too early given the increasing spotlight on data centers today and some changing regulations.

‘I recognize that the last time we spoke, I indicated that we expected to be done with an important transaction by this call, but we’re not ready to announce anything today,’ Dominguez said.

‘There is clearly more scrutiny on data center development,’ he added.”

It’s clear that growing public pushback on data centers is becoming a limiting factor in the AI investment binge.

Over at Barron’s, Avi Salzman suggested that the company’s failure to unveil any new data center deals as part of the festivities is also adding the the sell-off. He wrote:

“Constellation CEO Joe Dominguez said at the event that he anticipates signing major new deals to provide power to tech companies, but doesn’t want to announce anything too early given the increasing spotlight on data centers today and some changing regulations.

‘I recognize that the last time we spoke, I indicated that we expected to be done with an important transaction by this call, but we’re not ready to announce anything today,’ Dominguez said.

‘There is clearly more scrutiny on data center development,’ he added.”

It’s clear that growing public pushback on data centers is becoming a limiting factor in the AI investment binge.

markets

CoreWeave jumps after closing unique financing deal to borrow $8.5 billion backed by its chips and Meta’s AI compute purchases

Shares of CoreWeave are spiking on Tuesday after the company announced that it closed an $8.5 billion loan backed by its chips and what Meta is willing to pay to use them.

Last September, the neocloud reached an agreement to provide $14.2 billion worth of AI compute to the social media giant.

CoreWeave said the loan agreement is “the first investment-grade rated financing secured by HPC infrastructure and an associated customer contract.”

These terms helped to reduce CoreWeave’s cost of borrowing: this facility includes a floating rate (SOFR plus 2.25%, or about 5.9%) as well as a fixed rate tranche (at 5.9%). Last July, CoreWeave raised fixed-rate debt with a coupon of 9%.

In a world where Oracle’s five-year credit default swap spreads recently exceeded their 2008 peak, it’s nice to get some positive debt-related news in the AI realm.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.